C57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H

Status

Only small colony available

EMMA IDEM:16907
Citation informationRRID:IMSR_EM:16907 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H
Alternative nameHEPD0557_4_E10
Strain typeTargeted Mutant Strains
Allele/Transgene symbolElmod1tm1b(EUCOMM)Hmgu
Gene/Transgene symbolElmod1
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Mary Lyon Centre at MRC Harwell
Provider affiliationMary Lyon Centre at MRC Harwell
Genetic informationThis mouse line originates from EUCOMM ES clone HEPD0557_4_E10. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele (C57BL/6NTac-Tg(ACTB-cre)3Mrt/H). Click here for more information on EUCOMM final vectors.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (allele matching)
  • decreased leukocyte cell number / IMPC
  • decreased monocyte cell number / IMPC
  • tremors / IMPC
  • abnormal iris morphology / IMPC
  • decreased anxiety-related response / IMPC
  • abnormal locomotor behavior / IMPC
  • hyperactivity / IMPC
  • decreased locomotor activity / IMPC
  • abnormal gait / IMPC
  • head bobbing / IMPC
  • abnormal startle reflex / IMPC
  • decreased startle reflex / IMPC
  • trunk curl / IMPC
  • increased circulating phosphate level / IMPC
  • abnormal ear morphology / IMPC
  • increased mean corpuscular volume / IMPC
  • increased heart weight / IMPC
  • increased kidney weight / IMPC
  • increased heart rate variability / IMPC
  • increased lean body mass / IMPC
  • abnormal auditory brainstem response / IMPC
  • abnormal behavior / IMPC
  • decreased spleen weight / IMPC
  • increased eosinophil cell number / IMPC
  • decreased lymphocyte cell number / IMPC
  • cardiovascular system phenotype / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • increased blood urea nitrogen level / IMPC
  • decreased prepulse inhibition / IMPC
  • decreased total body fat amount / IMPC
  • decreased grip strength / IMPC
  • increased red blood cell distribution width / IMPC
  • shortened PR interval / IMPC
  • shortened PQ interval / IMPC
  • decreased large unstained cell number / IMPC
  • decreased thigmotaxis / IMPC
IMPC phenotypes (gene matching)
  • hyperactivity / IMPC
  • decreased prepulse inhibition / IMPC
  • abnormal locomotor behavior / IMPC
  • abnormal auditory brainstem response / IMPC
  • abnormal behavior / IMPC
  • increased startle reflex / IMPC
  • shortened PQ interval / IMPC
  • increased lean body mass / IMPC
  • decreased lymphocyte cell number / IMPC
  • decreased leukocyte cell number / IMPC
  • decreased thigmotaxis / IMPC
  • thrombocytopenia / IMPC
  • abnormal ear morphology / IMPC
  • decreased circulating glycerol level / IMPC
  • decreased large unstained cell number / IMPC
  • decreased locomotor activity / IMPC
  • abnormal startle reflex / IMPC
  • decreased circulating cholesterol level / IMPC
  • head bobbing / IMPC
  • abnormal gait / IMPC
  • decreased circulating HDL cholesterol level / IMPC
  • decreased anxiety-related response / IMPC
  • abnormal glucose homeostasis / IMPC
  • impaired pupillary reflex / IMPC
  • decreased grip strength / IMPC
  • increased circulating phosphate level / IMPC
  • increased red blood cell distribution width / IMPC
  • trunk curl / IMPC
  • increased circulating chloride level / IMPC
  • increased blood urea nitrogen level / IMPC
  • increased eosinophil cell number / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • abnormal response to tactile stimuli / IMPC
  • decreased B cell number / IMPC
  • abnormal locomotor activation / IMPC
  • tremors / IMPC
  • decreased monocyte cell number / IMPC
  • shortened PR interval / IMPC
  • decreased spleen weight / IMPC
  • decreased total body fat amount / IMPC
  • abnormal iris morphology / IMPC
  • increased heart rate variability / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • increased mean corpuscular volume / IMPC
  • cardiovascular system phenotype / IMPC
  • increased heart weight / IMPC
  • decreased startle reflex / IMPC
  • increased kidney weight / IMPC
MGI phenotypes (gene matching)
  • organ of Corti degeneration / MGI
  • circling / MGI
  • deafness / MGI
  • cochlear ganglion degeneration / MGI
  • abnormal cochlear hair cell stereociliary bundle morphology / MGI
  • hearing/vestibular/ear phenotype / MGI
  • absent startle reflex / MGI
  • increased or absent threshold for auditory brainstem response / MGI

Information on how we integrate external resources can be found here

Order (limited)

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).